- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $24M
- 2 Form D · Feb 2023
- 44 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 25 granted · 15 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2020202120222023
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $12,379,974 | |
| Private capital raised | Form D · SEC | $11,227,334 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2069 | Isomorphic Labs | — | — |
| 2070 | Courier Therapeutics Inc | — | — |
| 2071 | UNLOCKED LABS INC. | — | — |
| 2072 | Slingshot Biosciences | — | $24M |
| 2073 | ANI Energy, LLC | — | $1.5M |
| 2074 | Key Health Institute of Edmond, LLC | — | $100K |
| 2075 | RGENIX, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Nicolas BarthelemyDirector
- Jeffrey KimDirector · Executive Officer
- Andrew LeeDirector
- Corey RitterDirector
- Ronald SilbermanDirector
- Patrick WeissDirector
- Adam WieschhausDirector
Patents
- Size-tunable Synthetic Particles With Tunable Optical Properties And Methods For Using The Same For Immune Cell Activationgranted
- Synthetic Cells Comprising Tnf-related Apoptosis-inducing Ligand (trail) And Methods Of Using The Sameapplication
- Cytometric Control, Reference, And Calibration Using Hydrogel Particlesapplication
- Size-tunable Synthetic Particles For Immune Cell Activationapplication
- Compositions And Methods For Cell-like Calibration Particlesapplication
- Synthetic Human Cell Mimic Particle For Cytometric Or Coulter Deviceapplication
- Apoptotic Cell Mimicapplication
- CD34 Stem Cell Mimicsgranted
- Engineered Particles As Red Blood Cell Mimics And Compositions Containing Same For Hematologyapplication
- Engineered Particles As Red Blood Cell Mimics And Compositions Containing Same For Hematologygranted
- Synthetic Human Cell Mimic Particle For Cytometric Or Coulter Devicegranted
- Apoptotic Cell Mimicgranted
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.